# Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide

> **NCT00356265** · NA · TERMINATED · sponsor: **University of Michigan** · enrollment: 18 (actual)

## Conditions studied

- Chronic Kidney Disease
- Hypertension

## Interventions

- **DRUG:** Procedure: Regional phenylephrine arterial infusion

## Key facts

- **NCT ID:** NCT00356265
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Futility: Impossible to recruit enough hypertensive participants to match Chronic Kidney Disease (CKD) participants on needed parameters.
- **Last updated:** 2018-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356265, "Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00356265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*